GI-Revive

GI-Revive

Designs for Health4.8 (57 ratings)
Format:Capsule Quantity: 210 Capsule(s) · 30 servings
Goals
$99.99 $3.33 per serving

Product analysis

43 out of 100

GI-Revive combines glutamine and ingredients aimed at digestive-lining support. Everyday digestive benefit remains uncertain because the stronger glutamine findings involve selected circumstances and higher daily exposure.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The precise preparations are not specified well enough for close quality comparisons. That uncertainty affects the botanical mix as well as ingredients such as glutamine and zinc carnosine.

Ingredient Transparency63

The individual amounts are stated, making serving quantities easy to check. More precise form details are missing across the ingredient list.

Value For Money29

The glutamine, N-acetyl glucosamine and aloe contributions are relatively costly. The remaining ingredients do not provide a reliable value comparison to show whether the wider blend offsets those costs.

Customer Satisfaction73

Customer ratings are strongly positive, but the number of entries is small. Satisfaction is therefore less settled than it would be with a broader pool.

Product Focus54

The main purpose is digestive-lining support, with limited findings for additional skin-related uses. The long ingredient list makes it harder to identify which ingredients provide a meaningful contribution.

Format
Capsule
Container
210 Capsule(s)
Per serving
$3.33
Customer rating
4.8 · 57 ratings
Report analysis

Goals

Gut Health
Impact
Moderate effect
C- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Glutamine · 1500 mgN-Acetyl Glucosamine · 1000 mg

Glutamine relates to the fuel needs of intestinal lining cells, while aloe, zinc carnosine and demulcent botanicals relate to lining support. The strongest glutamine findings concern selected digestive conditions and higher daily exposure than the 1.5 g serving, so everyday benefit remains uncertain.

Pectin provides soluble fiber, but the 1 g serving is much smaller than the supplied trial exposure. Generic DGL licorice, slippery elm and N-acetyl glucosamine have limited or preparation-specific evidence, so their biological roles should not be read as established symptom relief.

How this product is rated for Gut Health

Ingredient fit58

The formula's digestive focus and declared amounts determine its ingredient fit.
Goal fit
Digestive ingredients share the formula with actives serving other goals, making its gut-health focus less direct.
Dose adequacy
The assessed amounts provide only partial support against the saved dose references.

Pathways16

The strongest assessed role is gastric mucosal defense, with limited coverage in the saved findings. No digestive role reaches the saved threshold for substantial coverage.
Depth
The strongest assessed role is gastric mucosal defense, with limited coverage in the saved findings.
Breadth
No digestive role reaches the saved threshold for substantial coverage.

Evidence75

Glutamine provides the strongest assessed evidence, with comparatively stronger support within the supplied digestive evidence. Preparation matching is partial; N-Acetyl Glucosamine lacks a studied-preparation match.
Evidence strength
Glutamine provides the strongest assessed evidence, with comparatively stronger support within the supplied digestive evidence.
Studied preparation
Preparation matching is partial; N-Acetyl Glucosamine lacks a studied-preparation match.

Formulation logic100

The assessed ingredients can contribute independently or have their required partners. No configured ingredient conflict was flagged in the saved assessment.
Partner coverage
The assessed ingredients can contribute independently or have their required partners.
Conflicts
No configured ingredient conflict was flagged in the saved assessment.
Effective doses
All assessed ingredients reach the saved minimum amount threshold.
Study evidence
Aloe Supportive 7 studies
Glutamine Supportive 37 studies
Joint Health
Impact
High effect
C- Ingredient FitD PathwaysB EvidenceA+ Formulation Logic
N-Acetyl Glucosamine · 1000 mg

N-acetyl glucosamine is a joint-formula building block, but the supplied evidence concerns cartilage biomarkers or combinations that do not isolate its clinical effect. It receives a saved allowance without established improvement in comfort or prevention. It is not interchangeable with glucosamine sulfate or hydrochloride. MSM is present at 100 mg per serving, below the saved minimum amount criterion.

How this product is rated for Joint Health

Ingredient fit59

N-acetyl glucosamine provides the main ingredient allowance. The counted amount reaches the full comparison range.
Goal fit
N-acetyl glucosamine supplies the main saved ingredient connection; broader product purposes and other actives affect focus.
Dose adequacy
N-acetyl glucosamine reaches the full saved amount comparison, which does not establish clinical effectiveness.

Pathways48

The saved findings center on cartilage matrix support. Coverage remains limited to that route.
Depth
The strongest saved contribution concerns cartilage matrix support; this does not demonstrate structural repair or a measured clinical effect.
Breadth
Only cartilage matrix support reaches the saved breadth criterion; the remaining assessed routes have no qualifying coverage.

Evidence79

Biomarker and combination studies do not establish an isolated clinical comfort or prevention benefit from N-acetyl glucosamine.
Evidence strength
Biomarker and combination studies do not establish an isolated clinical comfort or prevention benefit from N-acetyl glucosamine.
Studied preparation
The saved preparation allowance does not make N-acetyl glucosamine interchangeable with glucosamine sulfate or hydrochloride.

Formulation logic100

N-acetyl glucosamine meets the minimum amount criterion while MSM does not. No required partner or configured ingredient conflict is identified.
Partner coverage
No required ingredient partner is missing in the saved findings.
Conflicts
No configured ingredient conflict was identified.
Effective doses
N-acetyl glucosamine meets the saved minimum amount criterion; MSM falls below it, without proving MSM ineffective.
Study evidence
Sulfur Supportive 9 studies
Skin Health
Impact
High effect
C- Ingredient FitC- PathwaysA EvidenceA+ Formulation Logic
N-Acetyl Glucosamine · 1000 mg

N-acetylglucosamine may help dry-skin hydration, based on small studies in women with dry skin. The 1000 mg per serving is within the studied exposure range, but findings were limited and do not establish broad improvements in skin appearance. MSM is present at a much smaller amount than the identified preparation studied for ageing-related outcomes.

How this product is rated for Skin Health

Ingredient fit59

The counted ingredient amounts match the saved comparison. The practical skin connection depends on the specific ingredient and its evidence limitations.
Goal fit
Relevant skin ingredients sit within a broader formula containing ingredients without an assessed skin contribution.
Dose adequacy
The counted ingredients meet the saved amount comparison; this does not establish added benefit or an optimal daily intake.

Pathways58

Dermal hyaluronan and water binding is the strongest recorded connection; this describes the assigned ingredient roles, not a demonstrated product effect. The recorded coverage is concentrated in one skin role.
Depth
Dermal hyaluronan and water binding is the strongest recorded connection; this describes the assigned ingredient roles, not a demonstrated product effect.
Breadth
Only one skin pathway met the coverage threshold, so the recorded reach is narrow.

Evidence95

N-Acetyl Glucosamine leads the saved evidence finding, but its supplied clinical limitations still apply. Preparation matching does not remove those limitations.
Evidence strength
N-Acetyl Glucosamine leads the saved evidence finding, but its supplied clinical limitations still apply.
Studied preparation
The counted ingredients passed the saved preparation comparison; this does not confirm that the complete product matches a skin trial.

Formulation logic100

The counted contributions have no missing required partner or configured conflict. They all pass the saved minimum amount comparison.
Partner coverage
No required ingredient partner was missing among the counted contributions; no added combination benefit is established.
Conflicts
No configured ingredient conflict was identified among the evaluated contributions.
Effective doses
Every counted ingredient passed the saved minimum amount threshold; that threshold is not proof of clinical effectiveness.
Study evidence

Ingredients

IngredientAmount per servingScore
L-Glutamine
1500 mg 59
N-Acetyl Glucosamine
1000 mg 76
Citrus Pectin
1000 mg
Deglycyrrhizinated Licorice
400 mg
Aloe vera extract
300 mg 51
Slippery Elm
200 mg
Mucin
200 mg
Marshmallow
100 mg
Chamomile
100 mg
Okra extract
100 mg
Cat's Claw
100 mg
Methylsulfonylmethane
100 mg
Quercetin
100 mg
Prune powder
100 mg
Zinc Carnosine
75 mg
Gluten Free Adults 18–50
Report overview
B- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value
Each serving provides 1,000 mg of N-acetyl glucosamine, a larger amount. The product declares shellfish; that declaration alone does not establish the source of the N-acetyl glucosamine.
How this ingredient is rated

Active Ingredient Quality & Bioavailability74

N-acetyl glucosamine is named, but the saved facts do not specify the D isomer. The product declares shellfish; that declaration alone does not establish the source of the N-acetyl glucosamine.
N-Acetyl-D-Glucosamine Isomer Specificity
N-acetyl glucosamine is named, but the saved facts do not specify the D isomer.
Source and Allergen Disclosure
The product declares shellfish; that declaration alone does not establish the source of the N-acetyl glucosamine.

Dose, Safety & Label Transparency100

The serving discloses 1,000 mg of N-acetyl glucosamine, a larger amount.
NAG Potency per Serving
Each serving provides 1,000 mg of N-acetyl glucosamine, a larger amount.
Label Transparency and Blend Clarity
The amount of N-acetyl glucosamine is individually disclosed as 1,000 mg per serving.

Value30

The whole-product price works out to about $1.67 per 500 mg of N-acetyl glucosamine supplied.
Price per 500mg of N-Acetyl Glucosamine
The whole-product price works out to about $1.67 per 500 mg of N-acetyl glucosamine supplied.
Glutamine · 1500 mg OverallScore59
B- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyF Value
A serving provides 1500 mg of L-glutamine, a moderate amount. The whole-product price works out to about $2.22 per gram of L-glutamine.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

The saved facts identify L-glutamine but do not specify a grade.
Glutamine Grade & Purity
L-glutamine is the identified form; no specific grade is recorded in the saved facts.

Dose, Safety & Label Transparency70

The serving amount is individually listed at 1500 mg, a moderate amount.
Therapeutic Dosage Strength
A serving contains 1500 mg of L-glutamine, a moderate amount.
Label Transparency & Blends
The 1500 mg of L-glutamine is individually listed per serving.

Value15

The whole-product cost is about $2.22 per gram of L-glutamine.
Price per Gram of L-Glutamine
Based on the whole-product price, the cost is about $2.22 per gram of L-glutamine.
Aloe · 300 mg OverallScore51
F Composition And Label DisclosureA+ Composition And Label DisclosureF Commercial Price And Usability
Each serving lists 300 mg of aloe vera extract. The whole-product serving costs about $3.33.
How this ingredient is rated

Composition and Label Disclosure22

An aloe extract is recorded; a specific marker concentration is not established in the saved facts. The saved facts do not establish the aloe plant part or a purification process.
Aloe Part and Processing Disclosure
The saved facts do not establish the aloe plant part or a purification process.
Marker and Preparation Disclosure
An aloe extract is recorded; a specific marker concentration is not established in the saved facts.

Composition and Label Disclosure100

The aloe amount is individually disclosed as 300 mg per serving.
Individual Preparation Amount Disclosure
The aloe amount is individually disclosed as 300 mg per serving.

Commercial Price and Usability10

The whole-product serving costs about $3.33; that is not a separate price for aloe.
Commercial Price per Labeled Serving
The whole-product serving costs about $3.33; that is not a separate price for aloe.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Prevention of acute radiation-induced Proctitis by Aloe vera: a prospective randomized, double-blind, placebo controlled clinical trial in Pelvic Cancer patients.
    Sahebnasagh A; Ghasemi A; Akbari J; Alipour A; Lashkardoost H; Ala S; Hosseinimehr SJ; Salehifar E · BMC complementary medicine and therapies · 2020
    Randomized trial42 participantsGut Health forAloe
  2. Successful Treatment of Acute Radiation Proctitis with Aloe Vera: A Preliminary Randomized Controlled Clinical Trial.
    Sahebnasagh A; Ghasemi A; Akbari J; Alipour A; Lashkardoost H; Ala S; Salehifar E · Journal of alternative and complementary medicine (New York, N.Y.) · 2017
    Randomized trial20 participantsGut Health forAloe
  3. Aloe vera for Prevention of Acute Radiation Proctitis in Colorectal Cancer a Preliminary Randomized, Placebo-Controlled Clinical Trial.
    Sahebnasagh A; Saghafi F; Ghasemi A; Akbari J; Alipour A; Habtemariam S; Safdari M; Ghaleno HR; Salehifar E · Journal of gastrointestinal cancer · 2022
    Randomized trial20 participantsGut Health forAloe
  4. A Pilot Study of the Effect of Aloe barbadensis Mill. Extract (AVH200®) in Patients with Irritable Bowel Syndrome: a Randomized, Double-Blind, Placebo-Controlled Study.
    Størsrud S; Pontén I; Simrén M · Journal of gastrointestinal and liver diseases : JGLD · 2016
    Randomized trial68 participantsGut Health forAloe
  5. A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life.
    Hutchings HA; Wareham K; Baxter JN; Atherton P; Kingham JG; Duane P; Thomas L; Thomas M; Ch'ng CL; Williams JG · ISRN gastroenterology · 2011
    Randomized trial110 participantsGut Health forAloe
  6. Effect of perioperative glutamine-enriched nutritional support on patients with colorectal cancer: A systematic review and meta-analysis.
    Huang Y; Yang XZ; Qin SH; Zhang T; Xie M; Wang JW · World journal of gastrointestinal surgery · 2026
    Meta-analysis1,643 participants27 studies pooledGut Health forGlutamine
  7. Glutamine prevents diarrhea in colorectal cancer patients undergoing chemotherapy or chemoradiotherapy: a meta-analysis.
    Chen L; Wang D; Meng C; Sun H; Li R; Miao G; Liu P · BMC gastroenterology · 2025
    Meta-analysis311 participants5 studies pooledGut Health forGlutamine
  8. Glutamine supplementation reduces markers of intestinal permeability during running in the heat in a dose-dependent manner.
    Pugh JN; Sage S; Hutson M; Doran DA; Fleming SC; Highton J; Morton JP; Close GL · European journal of applied physiology · 2018
    Randomized trial10 participantsGut Health forGlutamine
  9. Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in children with acute diarrhea.
    Yalçin SS; Yurdakök K; Tezcan I; Oner L · Journal of pediatric gastroenterology and nutrition · 2004
    Randomized trial128 participantsGut Health forGlutamine
  10. Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial.
    Leite RD; Lima NL; Leite CA; Farhat CK; Guerrant RL; Lima AA · Arquivos de gastroenterologia · 2013
    Randomized trial46 participantsGut Health forGlutamine
  11. Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A randomized double-blind placebo-controlled clinical study.
    Tomonaga A; Watanabe K; Fukagawa M; Suzuki A; Kurokawa M; Nagaoka I · Experimental and therapeutic medicine · 2020
    Randomized trial65 participantsJoint Health forN-Acetyl Glucosamine
  12. Oral polymeric N-acetyl-D-glucosamine and osteoarthritis.
    Rubin BR; Talent JM; Kongtawelert P; Pertusi RM; Forman MD; Gracy RW · The Journal of the American Osteopathic Association · 2001
    Randomized trialJoint Health forN-Acetyl Glucosamine
  13. Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial
    Taishi Tsuji, Jieun Yoon, Naruki Kitano, Tomohiro Okura, Kiyoji Tanaka · Aging Clinical and Experimental Research · 2016
    Randomized trial50 participantsJoint Health forN-Acetyl Glucosamine
  14. Effects of sulfur bath on hip osteoarthritis: a randomized, controlled, single-blind, follow-up trial: a pilot study.
    Kovács C; Bozsik Á; Pecze M; Borbély I; Fogarasi A; Kovács L; Tefner IK; Bender T · International journal of biometeorology · 2017
    Randomized trial41 participantsJoint Health forSulfur
  15. Biomarkers of oxidation, inflammation and cartilage degradation in osteoarthritis patients undergoing sulfur-based spa therapies.
    Benedetti S; Canino C; Tonti G; Medda V; Calcaterra P; Nappi G; Salaffi F; Canestrari F · Clinical biochemistry · 2010
    Non-randomized trialJoint Health forSulfur
  16. [Sulphur mineral water and SPA therapy in osteoarthritis].
    Costantino M; Filippelli A; Quenau P; Nicolas JP; Coiro V · Therapie · 2013
    Single-arm trial99 participantsJoint Health forSulfur
  17. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial.
    Lubis AMT; Siagian C; Wonggokusuma E; Marsetyo AF; Setyohadi B · Acta medica Indonesiana · 2018
    Randomized trial147 participantsJoint Health forSulfur
  18. Balneotherapy for osteoarthritis.
    Verhagen AP; Bierma-Zeinstra SM; Boers M; Cardoso JR; Lambeck J; de Bie RA; de Vet HC · The Cochrane database of systematic reviews · 2008
    Systematic review498 participants7 studies pooledJoint Health forSulfur
  19. A randomized, investigator-blinded, controlled pilot study to evaluate the safety and efficacy of a poly-N-acetyl glucosamine-derived membrane material in patients with venous leg ulcers.
    Kelechi TJ; Mueller M; Hankin CS; Bronstone A; Samies J; Bonham PA · Journal of the American Academy of Dermatology · 2012
    Randomized trial82 participantsSkin Health forN-Acetyl Glucosamine
  20. Poly-N-acetyl glucosamine nanofibers for negative-pressure wound therapies.
    Fulco I; Erba P; Valeri RC; Vournakis J; Schaefer DJ · Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2016
    Randomized trial20 participantsSkin Health forN-Acetyl Glucosamine